Used primarily in organic synthesis, this compound serves as a key intermediate in the preparation of various pharmaceutical agents. Its boronic acid group enables it to participate in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in drug development. Additionally, the dimethylsulfamoyl moiety enhances its potential as a building block for molecules targeting specific biological pathways, such as enzyme inhibition. It is particularly valuable in the design of protease inhibitors and other therapeutic compounds. The compound's structure also makes it suitable for use in bioconjugation and labeling applications in biochemical research.